scispace - formally typeset
Search or ask a question
Author

Xingyu Jiang

Bio: Xingyu Jiang is an academic researcher from Southern University of Science and Technology. The author has contributed to research in topics: Medicine & Colloidal gold. The author has an hindex of 77, co-authored 467 publications receiving 25403 citations. Previous affiliations of Xingyu Jiang include Guangzhou Medical University & Beijing University of Chemical Technology.


Papers
More filters
Journal ArticleDOI
TL;DR: Soft lithography offers the ability to control the molecular structure of surfaces and to pattern the complex molecules relevant to biology, to fabricate channel structures appropriate for microfluidics, and topattern and manipulate cells.
Abstract: ▪ Abstract Soft lithography, a set of techniques for microfabrication, is based on printing and molding using elastomeric stamps with the patterns of interest in bas-relief. As a technique for fabricating microstructures for biological applications, soft lithography overcomes many of the shortcomings of photolithography. In particular, soft lithography offers the ability to control the molecular structure of surfaces and to pattern the complex molecules relevant to biology, to fabricate channel structures appropriate for microfluidics, and to pattern and manipulate cells. For the relatively large feature sizes used in biology (≥50 μm), production of prototype patterns and structures is convenient, inexpensive, and rapid. Self-assembled monolayers of alkanethiolates on gold are particularly easy to pattern by soft lithography, and they provide exquisite control over surface biochemistry.

2,659 citations

Journal ArticleDOI
Beatriz Pelaz1, Christoph Alexiou2, Ramon A. Alvarez-Puebla3, Frauke Alves4, Frauke Alves5, Anne M. Andrews6, Sumaira Ashraf1, Lajos P. Balogh, Laura Ballerini7, Alessandra Bestetti8, Cornelia Brendel1, Susanna Bosi9, Mónica Carril10, Warren C. W. Chan11, Chunying Chen, Xiaodong Chen12, Xiaoyuan Chen13, Zhen Cheng14, Daxiang Cui15, Jianzhong Du16, Christian Dullin5, Alberto Escudero17, Alberto Escudero1, Neus Feliu18, Mingyuan Gao, Michael D. George, Yury Gogotsi19, Arnold Grünweller1, Zhongwei Gu20, Naomi J. Halas21, Norbert Hampp1, Roland K. Hartmann1, Mark C. Hersam22, Patrick Hunziker23, Ji Jian24, Xingyu Jiang, Philipp Jungebluth25, Pranav Kadhiresan11, Kazunori Kataoka26, Ali Khademhosseini27, Jindřich Kopeček28, Nicholas A. Kotov29, Harald F. Krug30, Dong Soo Lee31, Claus-Michael Lehr32, Kam W. Leong33, Xing-Jie Liang34, Mei Ling Lim18, Luis M. Liz-Marzán10, Xiaowei Ma34, Paolo Macchiarini35, Huan Meng6, Helmuth Möhwald4, Paul Mulvaney8, Andre E. Nel6, Shuming Nie36, Peter Nordlander21, Teruo Okano, Jose Oliveira, Tai Hyun Park31, Reginald M. Penner37, Maurizio Prato9, Maurizio Prato10, Víctor F. Puntes38, Vincent M. Rotello39, Amila Samarakoon11, Raymond E. Schaak40, Youqing Shen24, Sebastian Sjöqvist18, Andre G. Skirtach41, Andre G. Skirtach4, Mahmoud Soliman1, Molly M. Stevens42, Hsing-Wen Sung43, Ben Zhong Tang44, Rainer Tietze2, Buddhisha Udugama11, J. Scott VanEpps29, Tanja Weil4, Tanja Weil45, Paul S. Weiss6, Itamar Willner46, Yuzhou Wu4, Yuzhou Wu47, Lily Yang, Zhao Yue1, Qian Zhang1, Qiang Zhang48, Xian-En Zhang, Yuliang Zhao, Xin Zhou, Wolfgang J. Parak1 
14 Mar 2017-ACS Nano
TL;DR: An overview of recent developments in nanomedicine is provided and the current challenges and upcoming opportunities for the field are highlighted and translation to the clinic is highlighted.
Abstract: The design and use of materials in the nanoscale size range for addressing medical and health-related issues continues to receive increasing interest. Research in nanomedicine spans a multitude of areas, including drug delivery, vaccine development, antibacterial, diagnosis and imaging tools, wearable devices, implants, high-throughput screening platforms, etc. using biological, nonbiological, biomimetic, or hybrid materials. Many of these developments are starting to be translated into viable clinical products. Here, we provide an overview of recent developments in nanomedicine and highlight the current challenges and upcoming opportunities for the field and translation to the clinic.

926 citations

Journal ArticleDOI
Yan Cui1, Yuyun Zhao, Yue Tian, Wei Zhang, Xiaoying Lü1, Xingyu Jiang 
TL;DR: This investigation would allow the development of antibacterial agents that target the energy-metabolism and transcription of bacteria without triggering the ROS reaction, which may be at the same time harmful for the host when killing bacteria.

630 citations

Journal ArticleDOI
TL;DR: In this paper, the authors summarized and reviewed recent advances in various promising and cutting-edge electrospinning techniques, including multilayering electro-spinning, post-processing after electro spinning, liquid-assisted collection, template assisted collection, porogen-added electro-spinning, and self-assembly.

561 citations

Journal ArticleDOI
TL;DR: A new strategy in designing antibacterial agents is illustrated--a series of commercially available compounds, amino-substituted pyrimidines, when presented on gold nanoparticles (NPs), show antibacterial activities against multidrug-resistant clinical isolates, without external sources of energy such as IR.
Abstract: This report illustrates a new strategy in designing antibacterial agents—a series of commercially available compounds, amino-substituted pyrimidines (themselves completely inactive as antibiotics), when presented on gold nanoparticles (NPs), show antibacterial activities against multidrug-resistant clinical isolates, without external sources of energy such as IR. These pyrimidine-capped gold NPs exert their antibiotic actions via sequestration of magnesium or calcium ions to disrupt the bacterial cell membrane, resulting in leakage of cytoplasmic contents including nucleic acids from compromised cell membranes, and via interaction with DNA and inhibition of protein synthesis by internalized NPs. These amino-substituted pyrimidine-capped gold NPs induce bacterial resistance more slowly compared with conventional, small-molecule antibiotics and appear harmless to human cells; these NPs may hence be useful for clinical applications.

509 citations


Cited by
More filters
Journal ArticleDOI

[...]

08 Dec 2001-BMJ
TL;DR: There is, I think, something ethereal about i —the square root of minus one, which seems an odd beast at that time—an intruder hovering on the edge of reality.
Abstract: There is, I think, something ethereal about i —the square root of minus one. I remember first hearing about it at school. It seemed an odd beast at that time—an intruder hovering on the edge of reality. Usually familiarity dulls this sense of the bizarre, but in the case of i it was the reverse: over the years the sense of its surreal nature intensified. It seemed that it was impossible to write mathematics that described the real world in …

33,785 citations

01 May 1993
TL;DR: Comparing the results to the fastest reported vectorized Cray Y-MP and C90 algorithm shows that the current generation of parallel machines is competitive with conventional vector supercomputers even for small problems.
Abstract: Three parallel algorithms for classical molecular dynamics are presented. The first assigns each processor a fixed subset of atoms; the second assigns each a fixed subset of inter-atomic forces to compute; the third assigns each a fixed spatial region. The algorithms are suitable for molecular dynamics models which can be difficult to parallelize efficiently—those with short-range forces where the neighbors of each atom change rapidly. They can be implemented on any distributed-memory parallel machine which allows for message-passing of data between independently executing processors. The algorithms are tested on a standard Lennard-Jones benchmark problem for system sizes ranging from 500 to 100,000,000 atoms on several parallel supercomputers--the nCUBE 2, Intel iPSC/860 and Paragon, and Cray T3D. Comparing the results to the fastest reported vectorized Cray Y-MP and C90 algorithm shows that the current generation of parallel machines is competitive with conventional vector supercomputers even for small problems. For large problems, the spatial algorithm achieves parallel efficiencies of 90% and a 1840-node Intel Paragon performs up to 165 faster than a single Cray C9O processor. Trade-offs between the three algorithms and guidelines for adapting them to more complex molecular dynamics simulations are also discussed.

29,323 citations

28 Jul 2005
TL;DR: PfPMP1)与感染红细胞、树突状组胞以及胎盘的单个或多个受体作用,在黏附及免疫逃避中起关键的作�ly.
Abstract: 抗原变异可使得多种致病微生物易于逃避宿主免疫应答。表达在感染红细胞表面的恶性疟原虫红细胞表面蛋白1(PfPMP1)与感染红细胞、内皮细胞、树突状细胞以及胎盘的单个或多个受体作用,在黏附及免疫逃避中起关键的作用。每个单倍体基因组var基因家族编码约60种成员,通过启动转录不同的var基因变异体为抗原变异提供了分子基础。

18,940 citations

Journal ArticleDOI
TL;DR: This paper presents a meta-analysis of the chiral stationary phase transition of Na6(CO3)(SO4)2, a major component of the response of the immune system to Na2CO3.
Abstract: Ju Mei,†,‡,∥ Nelson L. C. Leung,†,‡,∥ Ryan T. K. Kwok,†,‡ Jacky W. Y. Lam,†,‡ and Ben Zhong Tang*,†,‡,§ †HKUST-Shenzhen Research Institute, Hi-Tech Park, Nanshan, Shenzhen 518057, China ‡Department of Chemistry, HKUST Jockey Club Institute for Advanced Study, Institute of Molecular Functional Materials, Division of Biomedical Engineering, State Key Laboratory of Molecular Neuroscience, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China Guangdong Innovative Research Team, SCUT-HKUST Joint Research Laboratory, State Key Laboratory of Luminescent Materials and Devices, South China University of Technology, Guangzhou 510640, China

5,658 citations